You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《全日總結》恆指跌122點 商湯炒高四成 中藥股續揚
港股2022年首個交易日高開低走。恆指高開112點,早段曾升207點一度高見23,605點,午後曾跌204點一度低見23,193點,全日跌122點或0.53%,收23,274點;國指跌47點或0.58%,收8,188點;恆生科技指數跌30點或0.54%,收5,640點。大市全日成交總額699.81億元,滬、深港通因內地新年假期暫停,明日(4日)恢復。 匯控(00005.HK)跌0.1%報46.85元,港交所(00388.HK)跌0.2%報454.6元,友邦(01299.HK)升0.5%報79元。申洲(02313.HK)寧波部分廠房因爆發疫情短期停產,全日股價跌7.8%收138.2元。 科技股偏軟,騰訊(00700.HK)跌0.7%報453.8元,阿裏巴巴(09988.HK)回吐3.3%報115元,小米(01810.HK)跌1.6%報18.6元,美團(03690.HK)、京東(09618.HK)及百度(09888.HK)各跌0.7%至1.3%,快手(01024.HK)及衆安在線(06060.HK)各升3.5%及3%。 網絡醫療股阿裏健康(00241.HK)、平安好醫生(01833.HK)及京東健康(06618.HK)各跌3.4%至5.5%。商湯(00020.HK)急升40.9%報7.75元。晶片股華虹半導體(01347.HK)跌4.2%。 市傳恆大海花島39棟住宅規劃證被撤銷遭責令拆除,恆大(03333.HK)今早起停牌待刊發涉內幕消息公佈。其餘內房股受壓。融創(01918.HK)及世茂(00813.HK)各跌9.5%及6.9%,合景泰富(01813.HK)、龍光(03380.HK)及雅居樂(03383.HK)各跌5.4%至5.7%%。 物管股下滑,融創服務(01516.HK)及時代鄰裏(09928.HK)各挫12.5%及11.1%,保利物業(06049.HK)跌7.5%,雅生活(03319.HK)及碧桂園服務(06098.HK)各跌5.9%及4.5%。房地產軟件商明源雲(00909.HK)跌4.4%。 醫藥股表現兩極,中成藥研納入醫保藥品目錄,華潤醫藥(03320.HK)及中國中藥(00570.HK)各抽升31.5%及20.5%,培力農本方((01498.HK)抽升38.3%。生物醫藥股信達生物(01801.HK)跌8.7%,藥明生物(02269.HK)及藥明康德(02359.HK)各跌5.8%及7.1%。其他醫藥股方面,白雲山(00874.HK)及綠葉製藥(02186.HK)各升6%及6.2%。 航運股東方海外(00316.HK)、海豐(01308.HK)、中遠海控(01919.HK)及太平洋航運(02343.HK)各升4.9%至6.3%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account